Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Immunotoxin, MR1-1

NCT01009866 is registered in ClinicalTrials.gov with Darell D. Bigner, MD, PhD as lead sponsor.

NCT NCT01009866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01009866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Immunotoxin, MR1-1
Lead sponsor
Darell D. Bigner, MD, PhD
Phase
Phase 1
Overall status
Terminated
Start date
November 30, 2006
Completion date
December 31, 2012
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

supratentorial malignant brain tumor